All In MedTech

Device Trial Radar · NCT03246984

VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ

A Post Market Surveillance Multi-center Prospective Study to Evaluate the Safety and Efficacy of the VasQ External Support for Arteriovenous Fistula

Last checked: Nov 19, 2026Latest source record: Jan 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Sep 7, 2017

Primary completion

Jan 11, 2021

Study completion Jan 11, 2021

Sponsor

Lead sponsor
Laminate Medical TechnologiesNot on our public-company list
Sponsor type
Industry
First posted
Aug 11, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective single arm study enrolling patients who are scheduled for creation of a new Brachiocephalic or Radiocephalic AV fistula. Up to 80 patients will be enrolled, 50 with upper arm AV fistula and 30 with forearm AV fistula. All patients will be implanted with the VasQ device, a subcutaneous arteriovenous conduit support for vascular access. The follow up period in this study will be for a duration of 12 months, with follow up visits scheduled at 1, 3, 6, 9, and 12 months.

Conditions

  • Arterio-Venous Fistula
  • Kidney Failure, Chronic
  • Kidney Diseases
  • Renal Failure Chronic
  • ESRD
  • Arteriovenous Fistula Thrombosis

Interventions

  • VasQDevice

    VasQ device implantation in patients with a new brachiocephalic or radiocephalic fistula creation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary patency of AV fistulaTime frame: 6 months post AVF creation

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Institut Mutualiste Montsouris

    Paris, France

  • Universitätsklinikum Augsburg

    Augsburg, Germany

  • Charité - Universitätsmedizin Berlin

    Berlin, Germany

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.